Genus PLC (LON:GNS)
2,328p-1.27%
Spriggl Score: Good— see the number + sub-scores with a free Spriggl account
Last 30 trading days
Spriggl AI Verdict
“Animal genetics leader with FDA-approved gene-edited pig; earnings recovering fast and cash windfall due soon.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Genus PLC
Genus plc produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It of…
- Sector:
- Healthcare
- Industry:
- Biotechnology
- Market Cap:
- £1.6B
Recent dividends
- 5 Mar 202611.20p
- 6 Nov 202521.70p
- 6 Mar 202510.30p
Get the full Spriggl analysis — free
Sign up for a free Spriggl account to unlock the full Spriggl Score breakdown, screener, watchlist, and AI investment analysis on Genus PLC and 1,600+ UK and US stocks.
Start free